Inferior epigastric artery as a landmark for transfemoral TAVI. Optimizing vascular access?

Catheterization and Cardiovascular Interventions

Volumn 81, Issue 6, 2013, Pages 1061-1066

  Vavuranakis, Manolis ^a   Kalogeras, Konstantinos ^a   Vrachatis, Dimitrios ^a   Kariori, Maria ^a   Voudris, Vasilios ^b   Aznaouridis, Konstantinos ^a   Moldovan, Carmen ^a   Vaina, Sophia ^a   Lazaros, Georgios ^a   Masoura, Konstantina ^a   Thomopoulou, Sophia ^b   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

common femoral artery; inferior epigastric artery; TAVI; vascular complications

Indexed keywords

ADULT; AGED; AORTA STENOSIS; ARTERY PUNCTURE; ARTICLE; BIOPROSTHESIS; CONTROLLED STUDY; FEMALE; HEART VALVE BIOPROSTHESIS; HUMAN; INFERIOR EPIGASTRIC ARTERY; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PREDICTION; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL ANATOMY; TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR ACCESS; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ANATOMIC LANDMARKS; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; CATHETERIZATION, PERIPHERAL; CHI-SQUARE DISTRIBUTION; EPIGASTRIC ARTERIES; FEMALE; FEMORAL ARTERY; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; LOGISTIC MODELS; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PUNCTURES; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VASCULAR SYSTEM INJURIES;

EID: 84876466411     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24765     Document Type: Article

References (15)

1. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP, et al. Transcatheter valve implantation for patients with aortic stenosis: A position statement from the European association of cardio-thoracic surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). EuroIntervention 2008; 4: 193-199.
2. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
3. Vavuranakis M, Vrachatis D, Stefanadis C,. CoreValve aortic bioprosthesis: repositioning techniques. JACC Cardiovasc Interv 2010; 3: 565; author reply 565-566.
4. Hildick-Smith D, Redwood S, Mullen M, Thomas M, Kovac J, Brecker S, Trivedi U, Young C, Hutchinson N, Maccarthy P, et al. Complications of transcatheter aortic valve implantation: Avoidance and management. EuroIntervention 2011; 7: 621-628.
5. Vavouranakis M, Vrachatis DA, Toutouzas KP, Chrysohoou C, Stefanadis C,. "Bail out" procedures for malpositioning of aortic valve prosthesis (CoreValve). Int J Cardiol 2010; 145: 154-155.
6. Van Mieghem NM, Nuis RJ, Piazza N, Apostolos T, Ligthart J, Schultz C, de Jaegere PP, Serruys PW,. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. EuroIntervention 2010; 5: 673-679.
7. Tchetche D, Dumonteil N, Sauguet A, Descoutures F, Luz A, Garcia O, Soula P, Gabiache Y, Fournial G, Marcheix B, et al. Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population. EuroIntervention 2010; 5: 659-665.
8. Ducrocq G, Francis F, Serfaty JM, Himbert D, Maury JM, Pasi N, Marouene S, Provenchere S, Iung B, Castier Y, et al. Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. EuroIntervention 2010; 5: 666-672.
9. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: A consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011; 57: 253-269.
10. Sherev DA, Shaw RE, Brent BN,. Angiographic predictors of femoral access site complications: Implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv 2005; 65: 196-202.
11. Kawamura A, Piemonte TC, Nesto RW, Gossman DE,. Retroperitoneal hemorrhage from inferior epigastric artery: Value of femoral angiography for detection and management. Catheter Cardiovasc Interv 2006; 68: 267-270.
12. Spector KS, Lawson WE,. Optimizing safe femoral access during cardiac catheterization. Catheter Cardiovasc Interv 2001; 53: 209-212.
13. Vavuranakis M, Voudris V, Vrachatis DA, Thomopoulou S, Toutouzas K, Karavolias G, Tolios I, Sbarouni E, Lazaros G, Chrysohoou C, et al. Transcatheter aortic valve implantation, patient selection process and procedure: two centres' experience of the intervention without general anaesthesia. Hellenic J Cardiol 2010; 51: 492-500.
14. Eltchaninoff H, Kerkeni M, Zajarias A, Tron C, Godin M, Sanchez Giron C, Baala B, Cribier A,. Aorto-iliac angiography as a screening tool in selecting patients for transfemoral aortic valve implantation with the Edwards SAPIEN bioprosthesis. EuroIntervention 2009; 5: 438-442.
15. Hayashida K, Lefevre T, Chevalier B, Hovasse T, Romano M, Garot P, Mylotte D, Uribe J, Farge A, Donzeau-Gouge P, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv 2011; 4: 851-858.